ISEN Webinar Series

Stimulus Dosing in ECT: Current Practice and Future Directions
Harold Sackeim, PhD
Harold A. Sackeim, PhD
March 27, 2025
3:00pm ET
1.00 AMA PRA
Category 1 Credits
TM
The webinar will provide a review of how electrical parameters differ in shaping the electrical fields induced with ECT. This is a matter of biophysical investigation, including modeling, The various dosing strategies used in ECT will be described with discussion of their clinical utility in particular circumstances. Number of treatments will be raised as an essential dosing variable. Future directions, including spatial targeting, will be touched upon.
Objectives - After Attending This Program You Should Be Able To:
  • Improve understanding of how stimulus parameters impact on intracerebral electrical fields
  • Improve understanding of individual differences in dosing needs
  • Improve understanding of future directions
Continuing Education (CE) Language Statement
Webinar Pricing
Member
$25 USD
Non-Member
$50 USD
Non-Member Webinar Access - $50.00 USD
Sackeim, H.A., 2017. Modern Electroconvulsive Therapy: Vastly Improved yet Greatly Underused. JAMA Psychiatry 74, 779-780. https//doi.org/10.1001/jamapsychiatry.2017.1670.
Hazimeh, M., Sackeim, H.A., Nahas, Z., 2025. The Effects of Pulse Amplitude in Electroconvulsive Therapy on Seizure Threshold, Seizure Duration, and Time to Reorientation. Brain Stimul. https//doi.org/10.1016/j.brs.2025.01.023.
Sackeim, H.A., Prudic, J., Devanand, D.P., Nobler, M.S., Haskett, R.F., Mulsant, B.H., Rosenquist, P.B., McCall, W.V., 2020. The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode. Brain Stimul 13, 1284-1295. https//doi.org/10.1016/j.brs.2020.06.016.
Peterchev, A.V., Rosa, M.A., Deng, Z.D., Prudic, J., Lisanby, S.H., 2010. Electroconvulsive therapy stimulus parameters: rethinking dosage. J ECT 26, 159-174. https//doi.org/10.1097/YCT.0b013e3181e48165.
Continuing Education (CE) Language Statement
International Society for ECT & Neurostimulation (ISEN)
Webinar: Stimulus Dosing in ECT: Current Practice and Future Directions
March 27, 2025
Virtual
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
Jointly Accredited Provider logo
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for ECT & Neurostimulation (ISEN). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation #4008163.
Professions in scope for this activity are listed below.
Physicians
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Amedco LLC designates this activity for a maximum of 1.00 ANCC contact hours.
Psychologists
 American Psychological Association logo
This course is co-sponsored by Amedco and International Society for ECT & Neurostimulation (ISEN). Amedco is approved by the American Psychological Association to sponsor continuing education for psychologists. Amedco maintains responsibility for this program and its content. 1.00 hours.
The following state boards accept courses from APA providers for Psychologists/Counselors: AK, AR, AZ, CA, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, IO, KS, KY, MA (LEP ONLY), ME, MO, NC, ND, NH, NE, NJ, NM, NV, OK*, OR, PA, RI, SC, SD, TN, TX, UT, VA, WI, WY
The following state boards accept courses approved by any other state for Psychologists/Counselors: CO, MDMI: Accepts APA approved courses for Psychologists. No general CE requirements for counselors.
OK: Accepts APA credit for live, in-person activities but not for ethics and/or online courses.
The following state boards accept courses from APA providers for MFTs: AK, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IN, KS, MD, ME, MO, NE, NC, NH, NJ, NM, NV, OK*, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WDC, WI, WY
AL MFTs: Credits authorized by NBCC or any other state licensing agency will be accepted.
MA MFTs: Participants can self-submit courses not approved by the MAMFT board for review.
The following state boards accept courses from APA providers for Addictions Professionals: AK, AR, CO, CT, DC, DE, GA, IA, IN, KS, LA, MD, MO, MT, NC, ND, NE, NJ, NM, NY (held outside NY ONLY), OK*, OR, SC, UT, WA, WI, WY
The following state boards accept courses from APA providers for Social Workers: AK, AR, AZ, CA, CO, DE, FL, GA, ID, IN, KY, ME, MN, MO, NE, NH, NM, OR, PA, VT, WI, WY
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
NameCommercial Interest:Relationship
Harold Sackheim, PhDCerebral Therapeutics, Inc., Holhusk Inc., Neurolief LTD, NeuroInsights, Inc. Neuronietics Inc., Parow Entheobiosciences LLC, SigmaStim LLC:Consultant Harold Sackheim LivaNova, PLC, Neuronetics, Inc., SigmaStim LLC:Scientific/Medical Advisory Board Member; SigmaStim LLC:Patent Holder